Long-acting HIV treatment options for cisgender Black women in the Southern US
PS23-003 - A Community-based Assessment of Preferences for Long-Acting Antiretroviral Therapy Options Among Cis-gender Black Women across Six Ending the HIV Epidemic Jurisdictions in the South
This project talks with cisgender Black women with HIV in six Southern communities to learn which long-acting HIV treatments and support tools they prefer.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11138403 on NIH RePORTER |
What this research studies
You'll be invited to share your experiences, preferences, and barriers around long-acting injectable and other long-acting HIV treatments through interviews, surveys, and group discussions. The team will work across six Ending the HIV Epidemic (EHE) areas in the South and include younger women to capture local perspectives. Researchers and community partners will use what you tell them to co-create prototype education, referral, and linkage tools tailored for cisgender Black women. The work builds on earlier mixed-methods studies but focuses on real-world options now that long-acting ART is approved.
Who could benefit from this research
Good fit: Ideal candidates are cisgender Black women living with HIV in the project’s six Southern EHE jurisdictions, including younger women and those facing barriers to regular ART access.
Not a fit: People who are not cisgender Black women, who live outside the targeted Southern EHE areas, or who are not considering long-acting ART are unlikely to receive direct benefits from participating.
Why it matters
Potential benefit: If successful, the project could create education and referral tools that make it easier for cisgender Black women in the South to access and stay on long-acting HIV treatment, improving care engagement and viral suppression.
How similar studies have performed: Previous mixed-methods research collected women's opinions before long-acting ART approval and offered useful insights, but real-world uptake has been limited and tailored interventions for Southern cisgender Black women remain relatively new.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Collins, Lauren Frances — Emory University
- Study coordinator: Collins, Lauren Frances
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.